The new guidelines encourage patients to reduce or eliminate alcohol consumption entirely, compared with the old guidelines.
Baxdrostat improved ambulatory 24-hour average systolic blood pressure at 12 weeks compared with placebo in patients with ...
Baxdrostat, a novel aldosterone synthase inhibitor, demonstrated a highly clinically meaningful reduction in 24-hour ...
We're constantly told to "eat healthy" – but what does that actually mean? Even doctors sometimes struggle to offer clear, ...
Topline data were announced from a phase 3 trial evaluating baxdrostat in patients with treatment-resistant hypertension.
Positive high-level results from the Bax24 Phase III trial showed baxdrostat demonstrated a statistically significant and highly clinically meaningful reduction in ambulatory 24-hour average systolic ...
A new trial finds FFR-guided stenting spares patients unnecessary procedures in renal artery stenosis. Keep reading to see ...
With three-quarters of a century dedicated to advancing cardiovascular science and improving patient care, the ESC ...
• Blood pressure-lowering medications lower the chance of death and probably reduce heart attacks and strokes in people with hypertension (high blood pressure) 60 years of age or older. • There may be ...
Feeling dizzy or faint during pregnancy It could be low blood pressure Read ahead to know from an expert about what’s normal ...
Nearly half of all Americans have high blood pressure – a condition called hypertension. Hypertension is the No. 1 risk factor for heart disease and stroke. In addition, hypertension increases risk of ...
AZN's baxdrostat hit the main goal in the phase III Bax24 study, showing significant blood pressure reductions in patients ...